NCT07013591View on ClinicalTrials.gov

Nicotinamide Mmononucleotide in Patients Undergoing CABG Surgery

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2028

Study Completion Date

January 1, 2029

Conditions
Coronary Artery Bypass Graft
Interventions
DRUG

MIB-626

An orally-administered stable crystalline tablet formulation of NMN

OTHER

Placebo

matching placebo tablets

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Brigham and Women's Hospital

OTHER